NASDAQ:EXC • US30161N1019
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXELON CORP (EXC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-02 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-03-26 | Citigroup | Initiate | Buy |
| 2026-03-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-03-05 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-03-04 | Keybanc | Maintains | Underweight -> Underweight |
| 2026-02-20 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-13 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-02-13 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-27 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-22 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-28 | Wells Fargo | Initiate | Overweight |
| 2025-10-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-15 | Keybanc | Maintains | Underweight -> Underweight |
| 2025-10-15 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-10 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-07 | Evercore ISI Group | Initiate | Outperform |
| 2025-09-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-16 | Keybanc | Maintains | Underweight -> Underweight |
| 2025-07-11 | UBS | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.727B 13.89% | 23.028B 5.99% | 24.258B 5.34% | 25.402B 4.72% | 26.256B 3.36% | 27.113B 3.26% | 28.176B 3.92% | 29.452B 4.53% | |
| EBITDA YoY % growth | 7.519B 9.77% | 7.903B 5.11% | 8.788B 11.20% | 9.654B 9.85% | 10.418B 7.91% | 11.214B 7.64% | 12.284B 9.54% | 13.088B 6.55% | |
| EBIT YoY % growth | 4.013B 20.98% | 4.307B 7.33% | 5.145B 19.46% | 5.577B 8.40% | 5.992B 7.44% | 6.417B 7.09% | 6.877B 7.17% | 7.345B 6.81% | |
| Operating Margin | 18.47% | 18.70% | 21.21% | 21.95% | 22.82% | 23.67% | 24.41% | 24.94% | |
| EPS YoY % growth | 2.38 5.31% | 2.50 5.04% | 2.76 10.40% | 2.89 4.61% | 3.08 6.82% | 3.31 7.18% | 3.50 5.95% | 3.74 6.70% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.88 -4.49% | 0.49 25.64% | 0.91 5.42% | 0.61 3.98% | 0.96 8.81% | 0.51 4.44% | 0.95 4.35% | 0.67 9.21% | 1.04 8.27% | 0.50 -2.30% | 0.99 5.16% | 0.76 13.07% |
| Revenue Q2Q % growth | 7.114B 5.96% | 5.364B -1.16% | 7.074B 5.50% | 5.775B 6.71% | 8.438B 18.61% | 3.634B -32.25% | 8.122B 14.81% | 6.143B 6.37% | 8.757B 3.78% | 3.771B 3.77% | 8.429B 3.78% | 6.375B 3.78% |
| EBITDA Q2Q % growth | 2.639B 8.07% | 2.077B -23.95% | 2.657B -37.02% | 2.303B -52.28% | 1.76B -33.31% | 1.551B -25.32% | 1.729B -34.93% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.7B 10.61% | 1.015B 9.73% | 1.684B 12.27% | 1.298B 9.72% | 2B 17.65% | 861.07M -15.17% | 1.925B 14.31% | 1.456B 12.17% | 2.178B 8.90% | 938.07M 8.94% | 2.097B 8.94% | 1.586B 8.93% |
All data in USD
27 analysts have analysed EXC and the average price target is 51.73 USD. This implies a price increase of 7.44% is expected in the next year compared to the current price of 48.15.
EXELON CORP (EXC) will report earnings on 2026-05-06, before the market open.
The consensus EPS estimate for the next earnings of EXELON CORP (EXC) is 0.88 USD and the consensus revenue estimate is 7.11B USD.
The expected long term growth rate for EXELON CORP (EXC) is 3.52%.